As in so much of life, what we can readily see ahead of us in clinical research falls far short of telling us all there is to be known about the true extent of any particular subject.
Experts react to new study showing substantial net benefits for sponsors that use DCTs.
“There is room for African Americans at the leadership table.”
“DCTs are here to stay, but they won’t replace all traditional clinical trials,” former FDA official says.
“If you don’t diversify, educate, and raise the level of understanding” in the clinical trial workforce, it “makes it that much harder to achieve” your overall diversity goals, expert says.